Latest Breaking News On - Anthonyj olszanski - Page 2 : comparemela.com

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

/PRNewswire/ New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN Journal of the National.

United statesF marc stewartMehran yusufAndrewj armstrongMargaret temperoFacebook nccnorgInstagram nccnorgDaneng liLaurenp wallnerEmily bergslandAnthonyj olszanskiJunem mckoyKanishka sircarDuke cancer instituteDuke university medical centerPanel for neuroendocrine tumors

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesF marc stewartRachel darwinMehran yusufAndrewj armstrongMargaret temperoFacebook nccnorgInstagram nccnorgDaneng liLaurenp wallnerEmily bergslandAnthonyj olszanskiJunem mckoyKanishka sircarDuke cancer instituteDuke university medical center

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

United statesF marc stewartMehran yusufAndrewj armstrongMargaret temperoFacebook nccnorgInstagram nccnorgDaneng liLaurenp wallnerEmily bergslandAnthonyj olszanskiJunem mckoyKanishka sircarDuke cancer instituteDuke university medical centerPanel for neuroendocrine tumors

Not Just What, But When: Neoadjuvant Pembrolizumab in Melanoma

New trial results show that pembrolizumab given both before and after surgery for stage 2B-3 melanoma improved event-free survival compared with adjuvant therapy alone.

New yorkUnited statesFrance generalUnited kingdomFox chase cancer centerCity ofAnthonyj olszanskiSapna patelJames larkinMaya dimitrovaDevelopment agreementUniversity of texas md anderson cancer centerEuropean society for medical oncologyLangone perlmutter cancer centerCancer centerEuropean society

Blood Test for Many Cancers: More False Than True Positives

More results from the Pathfinder trial of the Galleri blood test for multiple cancers show that the test does detect cancer in healthy individuals, but it also has false positive results.

New yorkUnited statesMemorial sloan kettering cancer centerFrance generalFox chase cancer centerStanford universityDeborah schragAnthonyj olszanskiMax diehnAmerican society of clinical oncologyDrug administrationJournal of the american medical associationEuropean society for medical oncologyDepartment of medicineEuropean societyMedical oncology